Cubist Systematic Strategies’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $571K | Sell |
46,849
-122,517
| -72% | -$1.29M | ﹤0.01% | 2215 |
|
|
2025
Q2 | $1.35M | Sell |
169,366
-324,735
| -66% | -$2.28M | 0.01% | 1775 |
|
|
2025
Q1 | $3.59M | Sell |
494,101
-98,690
| -17% | -$717K | 0.02% | 1083 |
|
|
2024
Q4 | $4.08M | Sell |
592,791
-43,000
| -7% | -$296K | 0.03% | 957 |
|
|
2024
Q3 | $4.69M | Buy |
+635,791
| New | +$5.94M | 0.03% | 868 |
|
|
2024
Q2 | – | Sell |
-173,033
| Closed | -$2.39M | – | 3708 |
|
|
2024
Q1 | $2.39M | Sell |
173,033
-41,447
| -19% | -$647K | 0.01% | 1504 |
|
|
2023
Q4 | $4.17M | Buy |
214,480
+31,856
| +17% | +$588K | 0.03% | 983 |
|
|
2023
Q3 | $3.87M | Buy |
182,624
+31,002
| +20% | +$806K | 0.03% | 919 |
|
|
2023
Q2 | $5.03M | Buy |
+151,622
| New | +$5.58M | 0.03% | 842 |
|
|
2022
Q4 | – | Sell |
-72,300
| Closed | -$2.41M | – | 4486 |
|
|
2022
Q3 | $2.41M | Buy |
72,300
+45,527
| +170% | +$1.9M | 0.01% | 1807 |
|
|
2022
Q2 | $1.16M | Buy |
26,773
+14,673
| +121% | +$674K | 0.01% | 2360 |
|
|
2022
Q1 | $579K | Sell |
12,100
-23,979
| -66% | -$1.19M | ﹤0.01% | 2441 |
|
|
2021
Q4 | $1.83M | Sell |
36,079
-13,368
| -27% | -$594K | 0.02% | 1452 |
|
|
2021
Q3 | $2M | Buy |
49,447
+6,387
| +15% | +$323K | 0.03% | 1019 |
|
|
2021
Q2 | $2.44M | Sell |
43,060
-15,971
| -27% | -$909K | 0.03% | 962 |
|
|
2021
Q1 | $3.12M | Sell |
59,031
-17,907
| -23% | -$976K | 0.04% | 727 |
|
|
2020
Q4 | $4.2M | Sell |
76,938
-1,034
| -1% | -$54.4K | 0.06% | 524 |
|
|
2020
Q3 | $3.91M | Sell |
77,972
-63,871
| -45% | -$3.03M | 0.06% | 531 |
|
|
2020
Q2 | $5.42M | Buy |
141,843
+19,535
| +16% | +$628K | 0.09% | 306 |
|
|
2020
Q1 | $2.67M | Buy |
122,308
+65,899
| +117% | +$1.98M | 0.07% | 364 |
|
|
2019
Q4 | $2.31M | Sell |
56,409
-56,346
| -50% | -$2.3M | 0.04% | 669 |
|
|
2019
Q3 | $4.79M | Buy |
112,755
+12,491
| +12% | +$524K | 0.1% | 311 |
|
|
2019
Q2 | $4.95M | Buy |
100,264
+23,664
| +31% | +$1.2M | 0.09% | 308 |
|
|
2019
Q1 | $3.67M | Buy |
76,600
+50,231
| +190% | +$3.04M | 0.12% | 222 |
|
|
2018
Q4 | $1.62M | Buy |
26,369
+20,692
| +364% | +$1.4M | 0.08% | 368 |
|
|
2018
Q3 | $468K | Sell |
5,677
-7,847
| -58% | -$624K | 0.03% | 882 |
|
|
2018
Q2 | $1.06M | Buy |
13,524
+3,635
| +37% | +$282K | 0.05% | 455 |
|
|
2018
Q1 | $729K | Sell |
9,889
-17,785
| -64% | -$1.26M | 0.04% | 588 |
|
|
2017
Q4 | $1.89M | Buy |
27,674
+23,993
| +652% | +$1.55M | 0.1% | 251 |
|
|
2017
Q3 | $226K | Sell |
3,681
-5,434
| -60% | -$334K | 0.01% | 1367 |
|
|
2017
Q2 | $573K | Buy |
+9,115
| New | +$520K | 0.04% | 679 |
|
|
2017
Q1 | – | Sell |
-13,700
| Closed | -$655K | – | 1774 |
|
|
2016
Q4 | $655K | Buy |
13,700
+9,316
| +213% | +$522K | 0.05% | 541 |
|
|
2016
Q3 | $284K | Sell |
4,384
-1,688
| -28% | -$94.9K | 0.02% | 1042 |
|
|
2016
Q2 | $280K | Sell |
6,072
-8,115
| -57% | -$327K | 0.02% | 1126 |
|
|
2016
Q1 | $543K | Buy |
+14,187
| New | +$469K | 0.03% | 717 |
|
|
2015
Q3 | – | Sell |
-10,325
| Closed | -$487K | – | 1951 |
|
|
2015
Q2 | $487K | Buy |
10,325
+5,251
| +103% | +$284K | 0.02% | 979 |
|
|
2015
Q1 | $306K | Sell |
5,074
-12,944
| -72% | -$659K | 0.02% | 1240 |
|
|
2014
Q4 | $787K | Buy |
18,018
+8,100
| +82% | +$358K | 0.04% | 613 |
|
|
2014
Q3 | $447K | Buy |
+9,918
| New | +$528K | 0.03% | 899 |
|
Other funds holding NUS
PGCM
Cubist Systematic Strategies's NUS Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its Nu Skin (NUS) stake by 72% in Q3 2025, selling an estimated $1.29M and leaving 46,849 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #2215.
Cubist Systematic Strategies first reported a position in NUS in Q3 2014 and has held it in 39 quarters since. The position peaked at $5.42M in Q2 2020. 194 funds tracked by Wall St. Rank hold NUS as of Q3 2025.
- Cubist Systematic Strategies held 46,849 shares of Nu Skin worth $571K as of Q3 2025.
- Cubist Systematic Strategies sold 122,517 Nu Skin shares in Q3 2025, an estimated $1.29M.
- Nu Skin made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2215 holding.
- Cubist Systematic Strategies first reported a position in Nu Skin in Q3 2014 and has held it in 39 quarters since.
- Cubist Systematic Strategies's Nu Skin position peaked at $5.42M in Q2 2020.
- 194 funds tracked by Wall St. Rank held Nu Skin as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.